What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
His primary areas of investigation include Multiple myeloma, Internal medicine, Surgery, Transplantation and Oncology.
Michel Attal has researched Multiple myeloma in several fields, including Immunopathology and Dexamethasone.
His Internal medicine research integrates issues from Gastroenterology and Pathology.
His Surgery study deals with Urology intersecting with Vincristine.
The study incorporates disciplines such as Leukemia and Bone marrow in addition to Transplantation.
His Oncology research incorporates elements of Long term survival and Immunology.
His most cited work include:
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma (2415 citations)
- Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma (890 citations)
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma (795 citations)
What are the main themes of his work throughout his whole career to date?
Michel Attal mainly focuses on Internal medicine, Multiple myeloma, Oncology, Surgery and Transplantation.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Gastroenterology, with regards to Leukemia.
Much of his study explores Multiple myeloma relationship to Dexamethasone.
His studies in Oncology integrate themes in fields like Salvage therapy, Carfilzomib, Immunology and Daratumumab.
His Surgery study combines topics from a wide range of disciplines, such as Bone marrow and Urology.
His Transplantation research is multidisciplinary, incorporating elements of Survival rate, Stem cell and Fludarabine.
He most often published in these fields:
- Internal medicine (66.15%)
- Multiple myeloma (64.08%)
- Oncology (36.43%)
What were the highlights of his more recent work (between 2015-2021)?
- Multiple myeloma (64.08%)
- Internal medicine (66.15%)
- Oncology (36.43%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Multiple myeloma, Internal medicine, Oncology, Lenalidomide and Dexamethasone.
His studies deal with areas such as Newly diagnosed, Transplantation and Cancer research as well as Multiple myeloma.
His study looks at the relationship between Internal medicine and fields such as Stem cell, as well as how they intersect with chemical problems.
Within one scientific family, Michel Attal focuses on topics pertaining to Randomized controlled trial under Oncology, and may sometimes address concerns connected to Meta-analysis.
He has included themes like Surgery, Maintenance therapy, Phases of clinical research and Thalidomide in his Lenalidomide study.
His work carried out in the field of Surgery brings together such families of science as AL amyloidosis and Urology.
Between 2015 and 2021, his most popular works were:
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma (471 citations)
- Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group (359 citations)
- Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis. (264 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Chemotherapy
His main research concerns Multiple myeloma, Internal medicine, Lenalidomide, Bortezomib and Transplantation.
His study on Autologous stem-cell transplantation and Melphalan is often connected to In patient as part of broader study in Multiple myeloma.
His Internal medicine study typically links adjacent topics like Oncology.
His Lenalidomide research incorporates themes from Survival rate, Regimen, Surgery and Progression-free survival.
His research in Surgery tackles topics such as Urology which are related to areas like Survival analysis, Prospective cohort study and Neutropenia.
His Transplantation research incorporates elements of Thalidomide, Maintenance therapy, Immunology, Hazard ratio and Computed tomography.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
